Corporate Tech Investors

Alexandria Venture Investments

Alexandria Venture Investments is a corporate VC that invests in companies that are a good strategic fit.

Venture Investor Overview

Venture Investor
Alexandria Venture Investments
Status
Active
Investor Type
Corporate
Activity Level
267 transactions
Funds Raised
Unknown
Industry Focus
Biopharmaceutical
FoodTech
Healthcare IT
Healthcare Services
Life Sciences
Medical Devices & Instruments

Contact Information

Contact
Joel Marcus
Title
Chief Executive Officer
Mailing Address
385 East Colorado Blvd. 299
Pasadena, CA 91101
USA
Phone
(626) 578-0777
Website
www.are.com
Email Address
[email protected]

Background Information

Overview
Alexandria Real Estate Equities, Inc. (NYSE: ARE), a self-administered and self-managed real estate investment trust (REIT), is the largest and leading investment-grade REIT focused principally on owning, operating, redeveloping, developing, and acquiring high-quality, sustainable real estate for the broad and diverse life science industry.
Profile
Alexandria Venture Investments LinkedIn Company Profile
Social Media
Alexandria Venture Investments Company Twitter Account
Company News
Alexandria Venture Investments News
Facebook
Alexandria Venture Investments on Facebook
YouTube
Alexandria Venture Investments on YouTube
Last Transaction
12/5/2024

Transaction History

Our records indicate that Alexandria Venture Investments invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Company
Date
Amount
Nuvig Therapeutics
12/5/2024
$161,000,000
Autoimmunity BioSolutions
11/28/2024
$2,000,000
Valora Therapeutics
11/20/2024
$30,000,000
TRexBio
11/14/2024
$84,000,000
CrossBridge Bio
11/5/2024
$10,000,000
Leal Therapeutics
10/30/2024
$45,000,000
Archon Biosciences
10/30/2024
$20,000,000
March Biosciences
10/23/2024
$28,400,000
Passkey Therapeutics
10/22/2024
$20,000,000
Terray Therapeutics
10/17/2024
$120,000,000
Judo Bio
10/7/2024
$100,000,000
858 Therapeutics
9/27/2024
$50,000,000
Radiant Biotherapeutics
9/11/2024
$35,000,000
Outpace Bio
8/1/2024
$144,000,000
Airna
7/31/2024
$60,000,000
TwoStep Therapeutics
6/25/2024
$6,500,000
Ability Biologics
6/18/2024
$18,000,000
OverT Bio
5/6/2024
$16,000,000
Delphia Therapeutics
5/2/2024
$67,000,000
Enlaza Therapeutics
4/30/2024
$100,000,000
Mirador Therapeutics
3/25/2024
$400,000,000
Capstan Therapeutics
3/21/2024
$175,000,000
Umaro Foods
3/6/2024
$3,800,000
Neurona Therapeutics
2/9/2024
$120,000,000
Elo Life Systems
1/24/2024
$20,500,000
Remix Therapeutics
1/3/2024
$60,000,000
Tome Biosciences
12/13/2023
$213,000,000
Seismic Therapeutic
12/4/2023
$121,000,000
Alto Neuroscience
11/21/2023
$45,000,000
Triveni Bio
10/26/2023
$92,000,000
Deka Biosciences
9/28/2023
$20,000,000
Arialys Therapeutics
9/13/2023
$58,000,000
Georgiamune
8/9/2023
$75,000,000
Solu Therapeutics
8/1/2023
$31,000,000
AltPep
6/26/2023
$53,000,000
Ten63 Therapeutics
6/15/2023
$15,900,000
Mozart Therapeutics
6/7/2023
$25,000,000
Myeloid Therapeutics
5/18/2023
$73,000,000
Boundless Bio
5/16/2023
$100,000,000
Ten63 Therapeutics
5/2/2023
$15,900,000
Orbital Therapeutics
4/26/2023
$270,000,000
TORL BioTherapeutics
4/13/2023
$158,000,000
Function Oncology
4/12/2023
$28,000,000
Tiamat Sciences
3/9/2023
$2,000,000
Ring Therapeutics
3/9/2023
$86,500,000
Chroma Medicine
3/1/2023
$135,000,000
Garuda Therapeutics
2/7/2023
$62,000,000
IgGenix
2/7/2023
$40
Ensoma
1/10/2023
$85,000,000
Dantari
12/8/2022
$47,000,000
SonoThera
12/5/2022
$60,750,000
Cajal Neuroscience
11/29/2022
$96,000,000
Haystack Oncology
11/16/2022
$56,000,000
Matchpoint Therapeutics
10/17/2022
$100,000,000
Odyssey Therapeutics
10/13/2022
$168,000,000
Tavros Therapeutics
9/27/2022
$7,500,000
Novome Biotechnologies
9/13/2022
$43,500,000
Senda Biosciences
8/16/2022
$123,000,000
Ozette
7/28/2022
$26,000,000
Cartography Biosciences
7/19/2022
$57,000,000
Xilis
7/13/2022
$19,000,000
DEM BioPharma
6/23/2022
$70,000,000
Dren Bio
6/14/2022
$65,000,000
ImCheck Therapeutics
6/13/2022
$103,000,000
Pleno
5/25/2022
$15,000,000
Remix Therapeutics
5/18/2022
$70,000,000
Moma Therapeutics
5/10/2022
$150,000,000
Aspen Neuroscience
5/9/2022
$147,500,000
Pheast Therapeutics
4/26/2022
$76,000,000
Celsius Therapeutics
3/24/2022
Unknown
Affini-T Therapeutics
3/22/2022
$175,000,000
Eclipsebio
3/22/2022
$14,000,000
Creyon Bio
3/8/2022
$40,000,000
Kallyope
2/27/2022
$236,000,000
Terray Therapeutics
2/25/2022
$60,000,000
Ventus Therapeutics
2/18/2022
$140,000,000
Korro Bio
1/7/2022
$116,000,000
Ambys Medicines
12/22/2021
$47,000,000
NextVivo
12/10/2021
$7,900,000
Fountain Therapeutics
11/19/2021
$15,000,000
Parthenon Therapeutics
11/6/2021
$65,000,000
Mozart Therapeutics
10/30/2021
$55,000,000
Immunai
10/30/2021
$215,000,000
DNA Script
10/28/2021
$165,000,000
BIOMILQ
10/22/2021
$21,000,000
Kytopen
9/29/2021
$30,000,000
Rome Therapeutics
9/15/2021
$77,000,000
LEXEO Therapeutics
9/10/2021
$100,000,000
Disc Medicine
9/2/2021
Unknown
Asher Bio
9/2/2021
$108,000,000
Immunitas Therapeutics
8/19/2021
$58,000,000
Sonoma Biotherapeutics
8/5/2021
$265,000,000
SeQure Dx
8/4/2021
$17,500,000
Deep Genomics
7/29/2021
$180,000,000
IgGenix
7/28/2021
$25,000,000
AXONIS Therapeutics
7/15/2021
$5,000,000
ImmuneID
6/24/2021
$50,000,000
Neurona Therapeutics
6/23/2021
$41,500,000
TRexBio
6/23/2021
$59,000,000
Veralox Therapeutics
6/18/2021
$16,600,000
RayzeBio
6/16/2021
$108,000,000
Umoja Biopharma
6/16/2021
$210,000,000
Senda Biosciences
6/14/2021
$55,000,000
Kojin Therapeutics
6/10/2021
$60,000,000
miRecule
5/28/2021
$5,700,000
Invaio Sciences
5/26/2021
$88,900,000
Inari
5/14/2021
$208,000,000
TwinStrand Biosciences
5/7/2021
$50,000,000
Boundless Bio
4/29/2021
$105,000,000
Ventus Therapeutics
4/9/2021
$100,000,000
Alloy Therapeutics
4/3/2021
$75,000,000
StrideBio
3/17/2021
$81,500,000
insitro
3/16/2021
$400,000,000
Ensoma
2/12/2021
$70,000,000
Encodia
1/29/2021
$75,000,000
Vera Therapeutics
1/22/2021
$80,000,000
AltPep
1/19/2021
$23,150,000
Blacksmith Medicines
1/13/2021
Unknown
LEXEO Therapeutics
1/11/2021
$85,000,000
DiCE Molecules
1/11/2021
$80,000,000
Myeloid Therapeutics
1/7/2021
$50,000,000
Neurogene
12/17/2020
$115,000,000
Remix Therapeutics
12/9/2020
$81,000,000
RayzeBio
12/9/2020
$105,000,000
Vigil Neuroscience
12/9/2020
$50,000,000
Ubiq Security
11/19/2020
$6,400,000
Dren Bio
10/19/2020
$60,000,000
Knowledgehook
10/16/2020
$20,000,000
Sonoma Biotherapeutics
10/1/2020
$30,000,000
Korro Bio
9/11/2020
$91,500,000
Korro Bio
9/10/2020
$91,500,000
Vesigen Therapeutics
7/24/2020
$28,500,000
Vor Biopharma
7/8/2020
$110,000,000
TARA Biosystems
6/24/2020
$10,000,000
Autobahn Therapeutics
6/10/2020
$76,000,000
insitro
5/27/2020
$143,000,000
Nitrome Biosciences
4/23/2020
$38,000,000
Crop Enhancement
4/15/2020
$8,000,000
Affinia Therapeutics
4/1/2020
$60,000,000
Redpin Therapeutics
3/26/2020
$15,500,000
Kallyope
3/26/2020
$112,000,000
Silverback Therapeutics
3/12/2020
$78,500,000
Novome Biotechnologies
1/8/2020
$33,000,000
TwinStrand Biosciences
1/8/2020
$16,000,000
Triplet Therapeutics
12/18/2019
$59,000,000
Aspen Neuroscience
12/13/2019
$6,500,000
Jasper Therapeutics
12/10/2019
$35,000,000
Immunitas Therapeutics
11/22/2019
$39,000,000
Avidity Biosciences
11/14/2019
$100,000,000
Verseau Therapeutics
10/22/2019
$50,000,000
Adaptive Phage Therapeutics
10/8/2019
$7,000,000
Boundless Bio
9/20/2019
$46,400,000
X-Vax Technology
7/24/2019
$56,000,000
Cradle Genomics
7/17/2019
$17,100,000
GNS Healthcare
7/10/2019
$23,000,000
Encoded Therapeutics
6/27/2019
$104,000,000
BlackThorn Therapeutics
6/14/2019
$76,000,000
Strand Therapeutics
6/5/2019
$6,000,000
Inhibrx
5/23/2019
$40,000,000
Vividion Therapeutics
5/1/2019
$82,000,000
Arrakis Therapeutics
4/19/2019
$75,000,000
Karuna Therapeutics
4/2/2019
$12,000,000
Prevail Therapeutics
3/28/2019
$50,000,000
Cardea Bio
3/25/2019
$7,800,000
Imara Inc.
3/19/2019
$63,000,000
Karuna Therapeutics
3/19/2019
$68,000,000
Maze Therapeutics
3/1/2019
$191,000,000
Gencove
2/12/2019
$3,000,000
Dewpoint Therapeutics
1/31/2019
$60,000,000
Kinestral Technologies
1/31/2019
$100,000,000
GreenLight Biosciences
1/9/2019
$50,000,000
Frequency Therapeutics
1/8/2019
$42,000,000
Tiburio Therapeutics
1/4/2019
$31,000,000
Immusoft
1/4/2019
$20,000,000
Relay Therapeutics
12/21/2018
$400,000,000
Kallyope
12/6/2018
$21,000,000
Rheostat Therapeutics
11/27/2018
$23,000,000
NextCure
11/14/2018
$93,000,000
Ribometrix
11/14/2018
$30,000,000
Stoke Therapeutics
10/24/2018
$90,000,000
Inspirna
10/10/2018
$40,000,000
KSQ Therapeutics
9/29/2018
$80,000,000
MouSensor
9/26/2018
$3,300,000
Silverback Therapeutics
9/20/2018
$47,500,000
Benson Hill Biosystems
9/18/2018
$60,000,000
System1 Biosciences
9/13/2018
$25,000,000
OncoResponse
9/12/2018
$40,000,000
Biodesy
9/11/2018
$20,000,000
Magnolia Neurosciences
8/14/2018
$31,000,000
ORIG3N
7/13/2018
Unknown
Compass Therapeutics
7/13/2018
$49,000,000
Precision BioSciences
6/27/2018
$110,000,000
Cibus
6/27/2018
$70,000,000
Skyhawk Therapeutics
6/27/2018
$40,000,000
StrideBio
6/14/2018
$15,700,000
Metacrine
6/8/2018
$65,000,000
Celsius Therapeutics
5/16/2018
$65,000,000
Nohla Therapeutics
5/16/2018
$45,000,000
Proniras
4/30/2018
Unknown
QurAlis
4/6/2018
Unknown
TCR2 Therapeutics
3/22/2018
$125,000,000
IDEAYA Biosciences
3/16/2018
$94,000,000
Prevail Therapeutics
3/9/2018
$75,000,000
Quentis Therapeutics
2/28/2018
$48,000,000
Kallyope
2/23/2018
$66,000,000
Moderna
2/3/2018
$500,000,000
Skyhawk Therapeutics
1/24/2018
$8,000,000
Expansion Therapeutics
1/4/2018
$55,300,000
Aura Biosciences
12/22/2017
$30,000,000
Relay Therapeutics
12/15/2017
$63,000,000
Metacrine
12/8/2017
$22,000,000
Obsidian Therapeutics
12/7/2017
$49,500,000
Codiak BioSciences
11/30/2017
$76,500,000
Ribometrix
11/1/2017
$7,500,000
Cydan
10/18/2017
$34,000,000
Visterra
10/6/2017
$46,700,000
KSQ Therapeutics
10/3/2017
$76,000,000
LifeMine Therapeutics
9/19/2017
$55,000,000
Gritstone Oncology
9/8/2017
$92,700,000
Homology Medicines
8/2/2017
$83,500,000
Rodeo Therapeutics
7/26/2017
$5,900,000
eFFECTOR Therapeutics
7/25/2017
$38,600,000
Evelo Biosciences
7/12/2017
$50,000,000
Arsanis
4/27/2017
$45,500,000
Forge Therapeutics
4/26/2017
$15,000,000
Frequency Therapeutics
4/12/2017
$32,000,000
Antiva Biosciences
3/29/2017
$22,000,000
Benson Hill Biosystems
3/29/2017
$25,000,000
eGenesis
3/17/2017
$38,000,000
Boragen
3/3/2017
$10,000,000
Kinestral Technologies
2/1/2017
$65,000,000
Synthego
1/5/2017
$41,000,000
Molecular Assemblies
12/13/2016
$2,300,000
ApoGen Biotechnologies
12/13/2016
$7,000,000
BlackThorn Therapeutics
10/21/2016
$40,000,000
Aura Biosciences
9/30/2016
$8,000,000
Avelas Biosciences
8/19/2016
$20,000,000
Vtesse
7/26/2016
$17,000,000
Inspirna
6/16/2016
$33,000,000
IDEAYA Biosciences
5/5/2016
$46,000,000
Imara
4/15/2016
$31,000,000
Yumanity
2/11/2016
$45,000,000
EpiBiome
2/5/2016
$6,000,000
Codiak BioSciences
1/26/2016
$61,000,000
Lodo Therapeutics
1/13/2016
$17,000,000
Syros Pharmaceuticals
1/13/2016
$40,000,000
NextCure
1/7/2016
$67,000,000
WellDoc
12/18/2015
$22,000,000
Kallyope
12/11/2015
$44,000,000
GNS Healthcare
12/8/2015
$10,000,000
Codiak BioSciences
11/18/2015
$31,000,000
Biological Dynamics
11/9/2015
$26,800,000
Editas Medicine
8/10/2015
$120,000,000
Calimmune
5/28/2015
$15,000,000
Adaptive Biotechnologies
5/6/2015
$195,000,000
Aura Biosciences
3/5/2015
$21,000,000
Vtesse
1/8/2015
$25,000,000
Visterra
10/2/2014
$30,000,000
Flex Pharma
9/8/2014
$40,000,000
Seres Therapeutics
6/9/2014
$10,000,000
Integrated Diagnostics
4/29/2014
$47,250,000
Atara Biotherapeutics
1/10/2014
$13,500,000
Atara Biotherapeutics
12/18/2013
$38,500,000
Cydan
10/1/2013
$10,000,000
Cydan
4/12/2013
$16,000,000
Theraclone Sciences
3/25/2013
$14,000,000
Agrivida
9/12/2012
$15,160,828

 

Investor Contacts

Title
Name
Email & Social
Chief Executive Officer
Joel Marcus
  Joel Marcus LinkedIn Profile  Joel Marcus Twitter Account  Joel Marcus News  Joel Marcus on Facebook

 

Funds

No fund closings have been recorded for this company.

 

Portfolio Companies

Alexandria Venture Investments has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Tech Company
858 Therapeutics
Ability Biologics
Adaptive Biotechnologies
Adaptive Phage Therapeutics
Affini-T Therapeutics
Affinia Therapeutics
Agrivida
Airna
Alloy Therapeutics
Alto Neuroscience
AltPep
Ambys Medicines
Antiva Biosciences
ApoGen Biotechnologies
Archon Biosciences
Arialys Therapeutics
Arrakis Therapeutics
Arsanis
Asher Bio
Aspen Neuroscience
Atara Biotherapeutics
Aura Biosciences
Autobahn Therapeutics
Autoimmunity BioSolutions
Avelas Biosciences
Avidity Biosciences
AXONIS Therapeutics
Benson Hill Biosystems
Biodesy
Biological Dynamics
BIOMILQ
Blacksmith Medicines
BlackThorn Therapeutics
Boragen
Boundless Bio
Cajal Neuroscience
Calimmune
Capstan Therapeutics
Cardea Bio
Cartography Biosciences
Celsius Therapeutics
Chroma Medicine
Cibus
Codiak BioSciences
Compass Therapeutics
Cradle Genomics
Creyon Bio
Crop Enhancement
CrossBridge Bio
Cydan
Dantari
Deep Genomics
Deka Biosciences
Delphia Therapeutics
DEM BioPharma
Dewpoint Therapeutics
DiCE Molecules
Disc Medicine
DNA Script
Dren Bio
Eclipsebio
Editas Medicine
eFFECTOR Therapeutics
eGenesis
Elo Life Systems
Encoded Therapeutics
Encodia
Enlaza Therapeutics
Ensoma
EpiBiome
Evelo Biosciences
Expansion Therapeutics
Flex Pharma
Forge Therapeutics
Fountain Therapeutics
Frequency Therapeutics
Function Oncology
Garuda Therapeutics
Gencove
Georgiamune
GNS Healthcare
GreenLight Biosciences
Gritstone Oncology
Haystack Oncology
Homology Medicines
IDEAYA Biosciences
IgGenix
Imara
Imara Inc.
ImCheck Therapeutics
Immunai
ImmuneID
Immunitas Therapeutics
Immusoft
Inari
Inhibrx
insitro
Inspirna
Integrated Diagnostics
Invaio Sciences
Jasper Therapeutics
Judo Bio
Kallyope
Karuna Therapeutics
Kinestral Technologies
Knowledgehook
Kojin Therapeutics
Korro Bio
KSQ Therapeutics
Kytopen
Leal Therapeutics
LEXEO Therapeutics
LifeMine Therapeutics
Lodo Therapeutics
Magnolia Neurosciences
March Biosciences
Matchpoint Therapeutics
Maze Therapeutics
Metacrine
Mirador Therapeutics
miRecule
Moderna
Molecular Assemblies
Moma Therapeutics
MouSensor
Mozart Therapeutics
Myeloid Therapeutics
Neurogene
Neurona Therapeutics
NextCure
NextVivo
Nitrome Biosciences
Nohla Therapeutics
Novome Biotechnologies
Nuvig Therapeutics
Obsidian Therapeutics
Odyssey Therapeutics
OncoResponse
Orbital Therapeutics
ORIG3N
Outpace Bio
OverT Bio
Ozette
Parthenon Therapeutics
Passkey Therapeutics
Pheast Therapeutics
Pleno
Precision BioSciences
Prevail Therapeutics
Proniras
Quentis Therapeutics
QurAlis
Radiant Biotherapeutics
RayzeBio
Redpin Therapeutics
Relay Therapeutics
Remix Therapeutics
Rheostat Therapeutics
Ribometrix
Ring Therapeutics
Rodeo Therapeutics
Rome Therapeutics
Seismic Therapeutic
Senda Biosciences
SeQure Dx
Seres Therapeutics
Silverback Therapeutics
Skyhawk Therapeutics
Solu Therapeutics
Sonoma Biotherapeutics
SonoThera
Stoke Therapeutics
Strand Therapeutics
StrideBio
Synthego
Syros Pharmaceuticals
System1 Biosciences
TARA Biosystems
Tavros Therapeutics
TCR2 Therapeutics
Ten63 Therapeutics
Terray Therapeutics
Theraclone Sciences
Tiamat Sciences
Tiburio Therapeutics
Tome Biosciences
TORL BioTherapeutics
TRexBio
Triplet Therapeutics
Triveni Bio
TwinStrand Biosciences
TwoStep Therapeutics
Ubiq Security
Umaro Foods
Umoja Biopharma
Valora Therapeutics
Ventus Therapeutics
Vera Therapeutics
Veralox Therapeutics
Verseau Therapeutics
Vesigen Therapeutics
Vigil Neuroscience
Visterra
Vividion Therapeutics
Vor Biopharma
Vtesse
WellDoc
X-Vax Technology
Xilis
Yumanity

 

 

 

 

Browse more corporate investors:

Alex. Brown & Sons | Alexion Pharmaceuticals

 

Share this article

 

About Our Corporate Tech Investor Database

This corporate tech investor profile is powered by VentureDeal.com, a leading provider of corporate tech investing transaction data.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.